Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit percentage this year, helped by lower costs and growth from drugs such as eye ...
The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback